HuR as a molecular target for cancer therapeutics and immune-related disorders is a research paper published in Advanced Drug Delivery Reviews (2022). On theSindex it has a DataRank of 0. It has been cited 125 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA236379
NIDCR NIH HHS
Grant: R01 DE030013
NIDCR NIH HHS
Grant: R21 DE032461
NCATS NIH HHS
Grant: UL1 TR001450
National Institutes of Health
Grant: 1R01DE030013-01
Intersections of RNA-binding proteins and T-cells in oral epithelial plasticity
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals